Dexamethasone Sodium Phosphate Injection Shortage: Current Availability and Manufacturer Updates
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Dexamethasone Sodium Phosphate Injection is currently experiencing supply disruptions, with several manufacturers reporting backorders while others maintain available stock.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on February 11, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Drug Shortages — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA drug-shortage notice is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (drug-shortage, fda, medication, Dexamethasone) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What's in Shortage
Generic Name: Dexamethasone Sodium Phosphate Injection
Brand Name: DEXAMETHASONE SODIUM PHOSPHATE
Dosage Form: Injection
Therapeutic Categories: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pulmonary/Allergy, Rheumatology, and others.
Current Status: The shortage is currently active as of the latest update on February 5, 2026. This shortage was initially posted on February 8, 2019.
Which Manufacturers Are Affected
Supply availability varies significantly by manufacturer and specific product presentation:
Mylan Institutional, a Viatris Company (800-796-9526):
- Available: All listed presentations, including 4 mg/1 mL and 10 mg/1 mL injections.
Fresenius Kabi USA, LLC (888-386-1300):
- Available: 4 mg/1 mL (NDCs 63323-165-01, 63323-165-30, 63323-165-05), 10 mg/1 mL Preservative Free (NDC 63323-506-01), and 10 mg/1 mL (NDC 76045-109-10).
- Unavailable: 10 mg/1 mL (NDC 63323-516-10) with a next release date of March 2026; 4 mg/1 mL (NDC 76045-106-10) is currently not available.
Eugia US LLC (888-238-7880):
- Available: 10 mg/1 mL (NDC 55150-304-25).
- Unavailable: 4 mg/1 mL (NDCs 55150-238-05, 55150-237-01, 55150-239-30) and 100 mg/10 mL (NDC 55150-305-10) are on backorder with recovery dates to be determined.
Why There's a Shortage
The FDA source data does not provide a specific reason for the shortage, though several manufacturers indicate that specific presentations are currently on backorder.
What Patients Should Do
If you or a loved one relies on Dexamethasone Sodium Phosphate Injection, please consider the following steps:
- Consult Your Healthcare Provider: Speak with your doctor regarding your treatment plan. This article is for informational purposes and does not constitute medical advice.
- Talk to Your Pharmacist: Pharmacists often have the most up-to-date information on which specific NDCs (National Drug Codes) are currently in stock or available through wholesalers.
- Contact Manufacturers: You may use the contact numbers provided above to inquire about the availability of specific product presentations.
Source
Information provided by the FDA Drug Shortage Database. Last updated: February 5, 2026.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.
What is this FDA drug-shortage notice about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more Drug Shortages updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category